Skip to content

Therapeutic effects of osteoporotic patients treated with Teribone in patients with hip fracture

Therapeutic effects of osteoporotic patients treated with Teribone in patients with hip fracture

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0003852
Enrollment
104
Registered
2019-04-26
Start date
2018-05-15
Completion date
Unknown
Last updated
2019-05-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Gyeongsang National University Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Non-probabilistic extraction 1) Patients scheduled for surgery or underwent surgery due to hip fracture - Hip fractures include femoral neck, phalangeal fractures, and sub-electronic fractures. 2) Hip arthroplasty methods include bipolar artificial joint replacement, total hip arthroplasty, open reduction, and internal fixation. 3) Patients with osteoporosis and osteopenia (T-score: -2.0 or less in bone mineral density test) 4) randomized double blind with 52 subjects in the experimental group and 52 subjects in the control group.

Exclusion criteria

Exclusion criteria: 1) Pregnant women / lactating women (subjects with potential pregnancy should use appropriate methods of contraception (oral, physeal, mechanical, and surgical contraceptive methods) 2) patients with decreased renal function (creatinine clearance <35.0 mL / min), bone marrow diseases and malignant tumors (multiple myeloma, metastatic tumors, hemolytic anemia, leukemia, lymphoma) 3) hypocalcemia (serum calcium concentration less than 8 mg / dL or 2.0 mmol / L) 4) Patients who are sensitive to severe heart disease and PTH agents 5) Patients already taking other PTH preparations 6) Patients who should be excluded by judgment from researchers due to other medical and psychological problems 7) Patient who can not trust patient's cooperation

Design outcomes

Primary

MeasureTime frame
Increase in bone density

Secondary

MeasureTime frame
Activity level, walking time, KOVAL, blood test, Radiologically callus formation within 12 months CT, Dexa, x-ray

Countries

Korea, Republic of

Contacts

Public ContactSang youn song

Gyeongsang National University Hospital

songsangyoun@naver.com+82-55-750-9620

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026